Loading
IARC estimates 983 new cancer cases and 425 cancer deaths in French Polynesia in 2024; the commonest new cancers are prostate, breast and trachea, bronchus and lung. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for French Polynesia's mortality estimate is 3b: national incidence estimates applied to model-based mortality-to-incidence ratios (neighbouring country registry data). Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 204 | 92.3 | Prostate cancer |
| Breast | 164 | 82.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 156 | 37.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Thyroid | 61 | 16.4 | Thyroid cancer |
| Colorectum | 56 | 12.7 | Colorectal cancer |
| Stomach | 32 | 7.6 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 27 | 6.3 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Melanoma of skin | 24 | 6.1 | Melanoma |
| Corpus uteri | 23 | 11.7 | Endometrial cancer |
| Liver and intrahepatic bile ducts | 22 | 5.6 | Hepatocellular carcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 135 | 32.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 54 | 23.4 | Prostate cancer |
| Breast | 40 | 18.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 21 | 4.5 | Colorectal cancer |
| Stomach | 21 | 4.9 | Gastric & gastro-oesophageal junction cancer |
| Liver and intrahepatic bile ducts | 19 | 4.9 | Hepatocellular carcinoma |
| Non-Hodgkin lymphoma | 13 | 2.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Oesophagus | 12 | 2.6 | Oesophageal cancer |
| Cervix uteri | 9 | 4.5 | Cervical cancer |
| Pancreas | 9 | 2.1 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in French Polynesia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in French Polynesia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. French Polynesia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
French Polynesia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.